Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 186.86M | 189.06M | 179.99M | 172.84M | 165.78M |
Gross Profit | 163.72M | 94.58M | 84.84M | 89.87M | 68.14M |
EBITDA | 139.80M | 144.97M | 140.75M | 119.76M | 156.44M |
Net Income | 42.66M | 24.04M | -7.98M | -3.17M | 2.38M |
Balance Sheet | |||||
Total Assets | 2.01B | 2.10B | 2.22B | 500.14M | 3.21B |
Cash, Cash Equivalents and Short-Term Investments | 39.84M | 202.02M | 12.92M | 32.36M | 53.17M |
Total Debt | 563.41M | 564.31M | 3.87M | 27.41M | 963.74M |
Total Liabilities | 603.89M | 605.14M | 2.26M | 2.24M | 2.22M |
Stockholders Equity | 1.40B | 1.49B | 2.22B | 2.18B | 3.21B |
Cash Flow | |||||
Free Cash Flow | 129.86M | 125.75M | 113.23M | 111.66M | 80.90M |
Operating Cash Flow | 132.85M | 128.92M | 121.67M | 136.94M | 109.70M |
Investing Cash Flow | -149.69M | 197.31M | -142.81M | 1.23B | -41.42M |
Financing Cash Flow | -145.50M | -137.13M | 1.34M | -1.40B | -83.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $1.64B | 18.38 | 9.39% | 6.39% | 4.46% | 2.24% | |
74 Outperform | $483.44M | ― | -1.67% | 10.85% | 1.33% | -149.80% | |
72 Outperform | $1.34B | 38.37 | 2.46% | 6.56% | -2.94% | 46.24% | |
63 Neutral | $938.47M | ― | -13.96% | 1.03% | 5.33% | 10.68% | |
58 Neutral | $517.96M | 228.12 | 1.45% | 8.40% | -1.66% | -86.24% | |
58 Neutral | HK$21.35B | 22.20 | -16.35% | 14.62% | 7.50% | -107.03% | |
52 Neutral | $2.50B | ― | -28.86% | 7.69% | 19.56% | -12.73% |
On May 30, 2025, Sila Realty Trust, Inc. released an investor presentation for use at upcoming conferences and meetings. The presentation, which is available on the company’s website, outlines Sila’s focus on sustainable growth through long lease terms and rent growth in the healthcare sector. The company emphasizes strong governance, balance sheet discipline, and a commitment to high-quality healthcare facilities. Sila’s metrics, such as a 96% leased portfolio and a 9.7-year average remaining lease term, demonstrate its strong positioning compared to peers.
The most recent analyst rating on (SILA) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Sila Realty Trust, Inc. stock, see the SILA Stock Forecast page.
On May 21, 2025, Sila Realty Trust, Inc. held its Annual Meeting where stockholders elected six directors to serve until the 2026 Annual Meeting. Additionally, the stockholders approved the executive compensation on a non-binding basis, ratified KPMG LLP as the independent registered public accounting firm for 2025, and approved amendments to the Restricted Share Plan. These decisions are crucial for the company’s governance and financial oversight, potentially impacting its strategic direction and shareholder relations.
The most recent analyst rating on (SILA) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on Sila Realty Trust, Inc. stock, see the SILA Stock Forecast page.
On May 6, 2025, Sila Realty Trust’s board approved a quarterly cash dividend of $0.40 per share, payable on June 4, 2025. The company reported a net income of $7.1 million for Q1 2025 and highlighted strategic acquisitions in Knoxville, Tennessee, and Dover, Delaware, totaling $58.8 million. Sila Realty Trust entered a $600 million revolving credit agreement, enhancing its financial flexibility. The company’s strong financial position and strategic acquisitions underscore its commitment to investing in healthcare real estate, supporting long-term growth and stability.